GSK plc
GSK
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The compaā¦ read more
Healthcare
Drug ManufacturersāGeneral
45 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$48.02
Price+0.99%
$0.47
1Y
Price
Market Cap
$97.637b
Large
Price/Earnings 3y Avg5y Avg
13.8x
Premium
Premium
Financials Overview
Key metrics over the past few years+39.3%
EBITDA Margin+23.6%
Net Profit Margin+30.4%
Free Cash Flow MarginRevenue
$32.166b
+2.5%
1y CAGR+3.1%
3y CAGR+7.0%
5y CAGREarnings
$5.494b
+113.4%
1y CAGR-0.5%
3y CAGR+59.9%
5y CAGREPS
$7.32
+490.3%
1y CAGR+147.3%
3y CAGR+107.7%
5y CAGRBook Value
$21.206b
$82.578b
Assets$61.371b
Liabilities$23.896b
DebtDebt to Assets
28.9%
2.2x
Debt to EBITDAFree Cash Flow
$5.953b
+66.7%
1y CAGR+5.5%
3y CAGR+11.0%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company